Aptorum Group Limited (APM)
NASDAQ: APM · IEX Real-Time Price · USD
5.56
+0.06 (1.09%)
At close: Apr 24, 2024, 4:00 PM
5.89
+0.33 (5.94%)
After-hours: Apr 24, 2024, 7:58 PM EDT
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $23.19 million as of April 24, 2024. Its market cap has increased by 105.25% in one year.
Market Cap
23.19M
Enterprise Value
22.80M
1-Year Change
105.25%
Ranking
Category
Stock Price
$5.56
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $432.20M to $23.19M, a decrease of -94.63%. That is a compound annual growth rate of -42.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 28.50M | -2.73% |
Apr 22, 2024 | 29.30M | -1.68% |
Apr 19, 2024 | 29.80M | 7.19% |
Apr 18, 2024 | 27.80M | -26.06% |
Apr 17, 2024 | 37.60M | -5.05% |
Apr 16, 2024 | 39.60M | -2.70% |
Apr 15, 2024 | 40.70M | -4.24% |
Apr 12, 2024 | 42.50M | -4.71% |
Apr 11, 2024 | 44.60M | -3.46% |
Apr 10, 2024 | 46.20M | 3.13% |
Apr 9, 2024 | 44.80M | 1.36% |
Apr 8, 2024 | 44.20M | 6.51% |
Apr 5, 2024 | 41.50M | -22.57% |
Apr 4, 2024 | 53.60M | -2.01% |
Apr 3, 2024 | 54.70M | 5.39% |
Apr 2, 2024 | 51.90M | 3.39% |
Apr 1, 2024 | 50.20M | 2.03% |
Mar 28, 2024 | 49.20M | 9.09% |
Mar 27, 2024 | 45.10M | -1.74% |
Mar 26, 2024 | 45.90M | 13.90% |
Mar 25, 2024 | 40.30M | 0.25% |
Mar 22, 2024 | 40.20M | -4.06% |
Mar 21, 2024 | 41.90M | -4.77% |
Mar 20, 2024 | 44.00M | -11.82% |
Mar 19, 2024 | 49.90M | 22.91% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Enlivex Therapeutics | 24.54M |
Exagen | 24.13M |
Cue Health | 23.78M |
NeuroSense Therapeutics | 23.57M |
Cumberland Pharmaceuticals | 23.25M |
Biora Therapeutics | 22.93M |
Bullfrog AI | 22.85M |
Lumos Pharma | 22.70M |